Cargando…

Complete prevention of HTLV-1 infection in humanized mice (hu-PBL SCID) by a neutralizing monoclonal antibody to envelope gp46

Detalles Bibliográficos
Autores principales:	Saito, Mineki, Tanaka, Reiko, Kodama, Akira, Tanaka, Yuetsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045603/ http://dx.doi.org/10.1186/1742-4690-11-S1-O9

Ejemplares similares

Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
por: Tanaka, Yuetsu, et al.
Publicado: (2014)

A novel and simple method for generation of human dendritic cells from unfractionated peripheral blood mononuclear cells within 2 days: its application for induction of HIV-1-reactive CD4(+) T cells in the hu-PBL SCID mice
por: Kodama, Akira, et al.
Publicado: (2013)

The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice
por: Saito, Mineki, et al.
Publicado: (2014)

Generation of direct antigen-sandwich enzyme-linked immune-sorbent assays (ELISA) for quantitation of HTLV-1 gp46, p24, Tax and related host cellular antigens OX40, OX40L and CD25
por: Tanaka, Reiko, et al.
Publicado: (2014)

Successful development of novel monoclonal antibodies against HTLV-1 bZIP factor and their applications in studying the pathogenesis of HAM/TSP
por: Saito, Mineki, et al.
Publicado: (2011)

Identification of HIV-1 Epitopes that Induce the Synthesis of a R5 HIV-1 Suppression Factor by Human CD4(+) T Cells Isolated from HIV-1 Immunized Hu-PBL SCID Mice
por: Yoshida, Atsushi, et al.
Publicado: (2005)

A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I
por: Fujii, Hideki, et al.
Publicado: (2016)

The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
por: Okada, Masaji, et al.
Publicado: (2005)

A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL)
por: Tanaka, Yuetsu, et al.
Publicado: (2022)

Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras
Publicado: (1994)

Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status
por: Shiohama, Yasuo, et al.
Publicado: (2016)

Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
por: Okada, Masaji, et al.
Publicado: (2007)

Development of Vaccines and Passive Immunotherapy Against Sars Coronavirus Using Mouse and Scid-PBL/hu Mouse Models
por: Okada, Masaji, et al.
Publicado: (2006)

Critical Contribution of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) to Apoptosis of Human Cd4(+)T Cells in HIV-1–Infected Hu-Pbl-Nod-Scid Mice
por: Miura, Yoshiharu, et al.
Publicado: (2001)

EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses
por: Naito, Tadasuke, et al.
Publicado: (2019)

Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras
por: Tang, Yunlian, et al.
Publicado: (2011)

Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status
por: Shiohama, Yasuo, et al.
Publicado: (2017)

Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy
por: Hatayama, Yasuyoshi, et al.
Publicado: (2022)

Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor
por: Tezuka, Kenta, et al.
Publicado: (2018)

Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model
por: Zhou, Zhi-Feng, et al.
Publicado: (2019)

The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection
por: Steyaert, Sophia, et al.
Publicado: (2007)

Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Saito, Mineki, et al.
Publicado: (2013)

Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse
por: Satoh, Masaaki, et al.
Publicado: (2010)

Altered pattern in viral mRNA expression of Iranian type HTLV-1 leading to enhanced viral expression
por: Ueno, Takaharu, et al.
Publicado: (2014)

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses
por: Adachi, Tetsuya, et al.
Publicado: (2011)

Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice
por: Santini, Stefano M., et al.
Publicado: (2000)

Conservation of a Neutralization Epitope of Human T-cell Leukemia Virus Type 1 (HTLV-1) among Currently Endemic Clinical Isolates in Okinawa, Japan
por: Mizuguchi, Mariko, et al.
Publicado: (2020)

Genetic diversity in HTLV-1 envelope (gp46), HBZ And LTR region from assymptomatic And TSP/HAM individuals
por: Mota-Miranda, Aline C A, et al.
Publicado: (2011)

HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
por: Kovacs, JM, et al.
Publicado: (2012)

HTLV-1 infection of Humanized SCID mice recapitulates Adult T-cell Leukemia/Lymphoma (ATLL) development
por: Banerjee, Prabal, et al.
Publicado: (2009)

Evaluation of hGM-CSF/hTNFα surface-modified prostate cancer therapeutic vaccine in the huPBL-SCID chimeric mouse model
por: Lai, Shouhua, et al.
Publicado: (2015)

Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model
por: Brady, Jamie L, et al.
Publicado: (2014)

P1244: ROLE OF SELECT T HELPER CELL MONONUCLEAR CELL SUBSETS PROMOTING EPSTEIN-BARR VIRUS-DRIVEN LYMPHOPROLIFERATIVE DISEASE IN THE HU-PBL-SCID MODEL
por: Ahmed, E. H., et al.
Publicado: (2022)

Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses
por: Brunetti, Jesús Emanuel, et al.
Publicado: (2023)

Molecular mechanisms of apoptosis suppression by HTLV-1 bZIP factor in HTLV-1 infected cells
por: Tanaka-Nakanishi, Azusa, et al.
Publicado: (2014)

IFN-α suppresses HTLV-1 expression via PKR in infected cells and renders them susceptible to AZT through p53 activation in AZT/IFN-α treatment
por: Kinpara, Shuichi, et al.
Publicado: (2014)

The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Saito, Mineki, et al.
Publicado: (2017)

Association Between HTLV-1 Genotypes and Risk of HAM/TSP
por: Saito, Mineki
Publicado: (2019)

Long-term human hematopoiesis in the SCID-hu mouse
Publicado: (1990)

Bacteriophage protein Gp46 is a cross-species inhibitor of nucleoid-associated HU proteins
por: Zhang, Peipei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nvi200dtpl2n3fu8q9rsjuviaq